DBVT

#2262
DBV Technologies S.A.
22.24 USD
+0.45%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
22.20
22.47
Rango anual
7.00
26.19
Cambio diario
+0.45%
Variación mensual
+8.54%
Variación en los últimos 6 meses
+44.13%
Cambio anual
+200.95%
Cierres anteriores
22.14
Abrir
22.40
Bid
Ask
Mínimo
22.20
High
22.47
Volumen
37
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 1.32 B
  • Employee 125
  • Founded 2002
  • CEO N/A
  • Website www.dbv-technologies.com
  • Headquarter France
  • FIGI BBG0076D3T39
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-18.26
Relación precio/flujo de caja
474.74

DBV Technologies S.A. - American Depositary Shares

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Noticias